Results 191 to 200 of about 286,924 (257)
Some of the next articles are maybe not open access.
The Prostate, 2020
The early diagnosis of prostate cancer (PCa) is mainly based on prostate‐specific antigen (PSA) blood levels and digital rectal examination. However, this approach may result in a high rate of negative biopsies and increased detection of clinically ...
Nativ Omri +8 more
semanticscholar +1 more source
The early diagnosis of prostate cancer (PCa) is mainly based on prostate‐specific antigen (PSA) blood levels and digital rectal examination. However, this approach may result in a high rate of negative biopsies and increased detection of clinically ...
Nativ Omri +8 more
semanticscholar +1 more source
Cardiometabolic comorbidities in RA and PsA: lessons learned and future directions
Nature Reviews Rheumatology, 2019Cardiometabolic comorbidities present a considerable burden for patients with rheumatoid arthritis (RA) or psoriatic arthritis (PsA). Both RA and PsA are associated with an increased risk of cardiovascular disease (CVD).
Lyn D. Ferguson +3 more
semanticscholar +1 more source
Discordances entre les dosages de PSA : comparaison PSA, PSA libre, PSA complexé
Revue Française des Laboratoires, 1999Resume L'antigene specifique prostatique (PSA), combine au toucher rectal, represente aujourd'hui un outil performant dans la detection precoce du cancer de la prostate. Mais la variabilite des resultats en fonction des techniques de dosage en rend l'interpretation clinique delicate.
Yvonne Fulla +8 more
openaire +1 more source
ALIGN PsA: Advancing a Multidisciplinary Approach in PsA
Seminars in Cutaneous Medicine and Surgery, 2018Psoriasis is a chronic skin condition that is associated with several comorbidities and co-manifestations that reduce patient quality of life. Psoriatic arthritis (PsA) is a form of spondyloarthritis that is associated with psoriasis and typically involves peripheral disease, axial disease, enthesitis, dactylitis, and skin and nail lesions.
Eric W, Baum, Sergio, Schwartzman
openaire +2 more sources
Impact of race and baseline PSA on longitudinal PSA
International Journal of Cancer, 2005AbstractThere is an increasing debate regarding the frequency of prostate‐specific antigen (PSA) testing and the current primary screening modality used to detect prostate cancer. The purpose of this study is to determine whether PSA screening intervals should be based on initial PSA.
Katharine, McGreevy +4 more
openaire +2 more sources
Immuno-analytical characteristics of PSA and derived biomarkers (total PSA, free PSA, p2PSA)
Annales de Biologie Clinique, 2023Prostate-specific antigen (PSA) is the recommended tumor marker for individual screening and follow-up of prostate cancer. This paper reviews main structural and physiological data about prostate specific antigen isoforms: total PSA, free PSA, [-2]proPSA (also named p2PSA).
Cédric, Desbène +4 more
openaire +2 more sources
Relevance of total PSA and free PSA prescriptions
Annales de biologie clinique, 2018The total PSA testing has been frequently criticized for its effectiveness in the early detection of prostate cancer. These widely resumed in and out of the medical community have led to a decrease in prescriptions. Recommendations against the use of PSA for screening have been issued in France and in most countries.
Lamy, Pierre-Jean +4 more
openaire +3 more sources
Pro PSA : a “pro cancer” form of PSA?
Medical Hypotheses, 2005Pro PSA, the precursor of PSA, is an inactive 244-amino acid protein secreted by prostatic cells. Pro PSA, a distinct molecular form of free PSA in serum, includes native as well as several truncated forms. Clinical studies have recently provided evidence that pro PSA is associated with prostate cancer (PCa).
Michaël, Peyromaure +3 more
openaire +2 more sources
DBS of the PSA and the VIM in essential tremor
Neurology, 2018Objective To evaluate deep brain stimulation (DBS) of the posterior subthalamic area (PSA) in essential tremor (ET) and compare it to the ventral intermediate nucleus of the thalamus (VIM) in terms of stimulation efficacy, efficiency, and side effects ...
M. Barbe +14 more
semanticscholar +1 more source
Radiotherapy and Oncology, 2004
Several articles have appeared recently in Radiotherapy & Oncology [4,8,9,11,15,16] that warranted a critical reappraisal of the use of Prostate Specific Antigen (PSA) levels for determining in routine clinical practice whether or not the treatment of prostate cancer by radiotherapy was successful.
openaire +2 more sources
Several articles have appeared recently in Radiotherapy & Oncology [4,8,9,11,15,16] that warranted a critical reappraisal of the use of Prostate Specific Antigen (PSA) levels for determining in routine clinical practice whether or not the treatment of prostate cancer by radiotherapy was successful.
openaire +2 more sources